Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT)
Lung Cancer, Advanced Cancer, Caregiver Burden
About this trial
This is an interventional supportive care trial for Lung Cancer focused on measuring lung cancer, palliative care, Acceptance and Commitment Therapy, cancer-related fatigue, caregiver burden
Eligibility Criteria
Inclusion Criteria: aged 18 or over; diagnosed with stage III or stage IV lung cancer by pathological section or cytology; lived in rural areas; experienced unexplained fatigue syndrome: the score of 3 or more on the Fatigue Symptom Inventory (FSI); able to provide informed consent and effectively collect data; a consenting primary family caregiver; and working phone service Exclusion Criteria: diagnosed with cognitive dysfunction or other mental illnesses that may interfere with their completion of treatment; who are at critical condition; and who are receiving or have just completed other lung cancer-related intervention programs within the last six months
Sites / Locations
- Xiangya Hospital Central South University
Arms of the Study
Arm 1
Arm 2
Experimental
Other
ACT group
Health eduction control group
Participants in the intervention group will receive ACT intervention, consisting of six online sessions via video conferencing platform (The first two sessions for patient only, the third and fourth sessions for caregiver only, and the last two sessions for patient-caregiver dyads) of 60-90 min each (once/week), in addition to health education.
Participants randomised to the health education control group will receive six weekly health education by a video-conferencing platform. The topics mainly include treatments and daily care during admission, medication instructions and side effects, diet and exercise advice, and retest recommendations when discharged.